ABSTRACT Introduction
INTRODUCTION
It is well known that people with rheumatoid arthritis (RA) have higher mortality compared to the general population and primarily due to an increased risk of cardiovascular (CV) events (Avina-Zubieta et al. 2012 , Gullick and Scott 2011 , Meune et al. 2009 , Meune et al. 2010 . The excess CV risk (CVR) appears to be caused by both the inflammatory process and an increased prevalence of some of the traditional risk factors for development of CV disease (del Rincon et al. 2001 , Innala et al. 2011 , Solomon et al. 2010 ).
In 2010 the European League Against Rheumatism (EULAR) published recommendations for CVR management (Peters et al. 2010) , which advocated screening and CVR assessment in all patients with RA according to local guidelines or with the systematic coronary risk evaluation (SCORE) system. SCORE is a multiple traditional risk factor assessment equation based on gender, smoking, age, systolic blood pressure and total-/High Density Lipoprotein (HDL) cholesterol ratio (Peters et al. 2010 , Conroy et al. 2003 . In order to adjust for the extra risk in patients with RA, this SCORE should be adapted by a multiplication factor of 1.5 if the patient meets two of the following three criteria: a) disease duration ≥ 10 years; b) rheumatoid factor and/or anticyclic citrullinated peptide (anti-CCP) positivity; and c) the presence of certain extra-articular manifestations, thereby creating the modified mSCORE (Crowson et al. 2012 , Peters et al. 2010 . A focus on controlling the patients' disease activity is also very important in order to lower the patient's risk for CV disease (Peters et al. 2010) . When the EULAR guidelines for CVR management were published in 2010 (Peters et al. 2010) , there was limited evidence for patients with Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA). Later studies have supplemented the evidence for an increased risk for them as well, although the evidence that inflammation affects the risk for ischemic heart disease is less conclusive than in RA (Ernste et al. 2015 , Jamnitski et al. 2011 , Papagoras et al. 2013 , Khraishi et al. 2014 , Mathieu et al. 2014 , Parisi et al. 2015 , Essers et al. 2014 CVR assessment and management in people with different types of medical conditions involve different health professionals, but across the world nurses in different settings are increasingly undertaking this task (Olde et al. 2013 , Rice et al. 2013 , Nieuwkerk et al. 2012 , Boase et al. 2012 , Deaton et al. 2011 , Berra 2011 , Osborn et al. 2010 , Morris et al. 2009 , Fair et al. 2009 , Jansink et al. 2009 , Hoebeke 2008 .
EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis (IA) (van Eijk-Hustings et al. 2012 ) encourage nurses to carry out interventions and monitoring as part of comprehensive disease management in these patients. These recommendations also identified the need to define the contribution of the nurse in the prevention of comorbidities in patients with IA (van EijkHustings et al. 2012 ).
The aim of this paper was to explore nurses' role in assessing and managing CVR in Europe, in order to suggest topics for practice development and research in this area regarding persons with IA.
METHODS
We conducted a systematic literature review and provided practical examples of CVR assessment and management in patients with IA in five European countries. The questions that guided the literature search were (i) how do nurses assess CVR in Europe? and (ii) how do nurses manage CVR in Europe?
The literature review is followed by case studies from five different countries to illustrate national guidelines and nurses' role regarding CVR assessment and management in patients with IA.
Literature review

Literature search
We searched five electronic databases supplemented by a hand search in the reference lists of the included articles. In Embase, CINAHL, Cochrane and PsycInfo we used the search terms: "nurs*" AND "cardiovascular risk" and in PubMed MEDLINE we used "cardiovascular risk" AND the MeSH term for "nursing". The searches were limited to full text, and to the past 10 years in order to represent recent practice. The inclusion criteria were: (i) studies from Europe, (ii) published from June 2004 through June 2014, (iii) studies reporting descriptions of nurse-led assessment and or management of CVR. Studies were excluded if they only described a protocol, involved children or adolescents or were written in languages other than English, Portuguese, Spanish, Italian, French, Swedish, Norwegian or Danish.
Duplicates were discarded. In March 2015 the searches were updated in order to identify relevant articles published from June 2014 through February 2015.
Study selection
Two reviewers (RF and JP) independently screened the titles and abstracts according to the selection criteria. In the screening process, disagreements were discussed until consensus was reached. The articles selected for full text screening were divided between five reviewers (JP, RF, SG, MN and YvE). Each reviewer screened the full texts independently and made a judgement for inclusion/exclusion and documented their reasons based on the predefined inclusion/exclusion criteria. Where the reviewer had doubts, the article was assessed by a second reviewer too before inclusion. Finally the list of included articles was discussed among all authors in order to achieve agreement.
Data extraction
Data extraction was performed using a predefined data extraction form which included: authors, journal, title, publishing date, type of study, number of patients included, medical diagnoses or risks, content of the nurse-led risk assessment and, if done, how nurses managed the identified risk factors. Data extraction was performed independently by each reviewer and then two reviewers (RF and YvE) independently checked the accuracy of the data against the included articles. The data from these forms were synthesized descriptively. See Table 1 .
RESULTS
Of the 65 eligible articles, 25 satisfied the inclusion criteria and three were added via hand search.
Through the updated search we identified five additional articles, resulting in a total of 33 included articles ( Figure 1 ).
Screening
Included
Eligibility
Identification
Pubmed MEDLINE (n = 233)
Records obtained (n = 878)
Records screened (n =766)
Records duplicated (n = 112)
Full-text articles assessed for eligibility (n =65)
Full-text articles excluded (n =40) three pre-test post-test studies, three discursive articles and two qualitative studies.
The settings of nurse-led assessment of CVR
The included clinical studies showed that European nurses undertake CVR assessment in many different settings such as primary health care (general practice and or in the community) (n=16) or in hospitals (n=15).
Type of patients
Apart from assessment of CVR in the general population (n=3), nurses also undertake risk assessment in patients with one or more already known elevated CVR factors (n=12), known CV diseases (n=5) and in patients with a specific increased risk such as chronic kidney disease (n=4), diabetes (n=2), psychiatric diseases (n=2) or rheumatoid arthritis (n=2).
The content of the nurse-led risk assessments
The included studies describe that nurses usually perform a general risk assessment and check whether treatment goals are achieved (Table 1 ). The variables included in the nurses' general CVR assessments usually follow recommendations from the national associations for General Practitioners (GPs), hypertension, diabetes or cardiology associations.
The nurses risk assessment includes the measurement of resting blood-pressure (BP) (sitting in a chair and after at least 5 minutes rest) and lipids (all or some of the following: total-, High Density Lipoprotein (HDL)-, Low Density Lipoprotein (LDL)-cholesterol and Triglycerides). In addition, the nurses often assess behavioural risk factors (unhealthy diet, physical inactivity, excess alcohol and smoking), overweight and obesity estimated by Body Mass Index (BMI) and in some cases also waist circumference (Table 1) . In three studies the nurses assess both waist and hip circumference (#1, 23 and 28) and calculate a waist/hip ratio. Family history of or known ischemic CV disease and known diabetes or are often included in the nurses' assessment as well as glucose level. In four studies the presence of metabolic syndrome was assessed (including assessment of abdominal obesity or waist circumference, atherogenic dyslipidaemia, increased BP and insulin resistance) (#6, 16, 28 and 29) . Homocysteine level and/or coagulation profile was included in a few studies (#29 and 31). The assessment of stress was described in two of the studies and ankle brachial index in one study (#16). In addition more disease specific measures such as thyroid (#11 and 18), kidney function (#27, 28 and 32), left ventricular hypertrophy (#24) or heart rate (#29) were assessed depending on the type of patients. In this article we will not focus further on these disease specific assessments.
It is also described that nurses assess the patients' motivation for change in risk-related behaviour (#4, 10, 11, 23, 29 and 32), socioeconomic status (#10 and 17) or educational level (#6), and the availability of health services for further support (#4 and 10) ( Table 1 ).
In one study (#17), nurses used additional questionnaires to assess saturated fat, fruit and vegetable intake and physical exercise. In one study the nurses assessed the participants' risk perception and anxiety (#17), and two studies described the assessment of satisfaction or confidence in decisions (#17 and 19).
Risk calculation
Different tools were used to calculate the patients´ absolute risk for CV death in 10 years, being the European SCORE system the most used (n=8). See Table 1 . Other tools used were the Framingham (n=4) and the modified Framingham (n=1) and the UK Prospective Diabetes Study Risk engine for diabetic patients (n=1).
Nurse-led interventions and management of patients' CVR
Nurses' role in the management of patients' CVR in Europe varied in the identified studies, from brief advice to comprehensive and long-term follow-up. Different roles were described regarding the patients' pharmacological therapy (Table 1 ) such as creating an overview over the patients' current medication, their preference for medication, adherence or compliance to CVR therapy as well as other types of medication. While in some studies nurses titrated antihypertensive or cholesterol lowering medications (#5, 11, 19 and 25) , in others, the results of the nurse assessments were used as a basis for initiation or titration of pharmacological therapy by the rheumatologist or GP (#4 and 8).
The nurses' approach is mainly described as being holistic, individually tailored and based on shared decision making. Nurses aim to empower the patient or increase the patients' self-management abilities or self-efficacy and to take ownership of their risk.
The nurses offer education, additional information materials (in different formats such as leaflets and DVDs), individualized advice and coaching regarding healthy low fat balanced diet, how to lose weight, increase physical activity, reduce alcohol consumption, smoking cessation, adherence to medication and risk perception. Motivational Interviewing is described as a common tool used in discussions regarding life-style (#5, 11, 12, 17 and 20) . Nurses also help patients set realistic and achievable goals and how to evaluate them. Some of the included studies describe that the participants were offered additional tools such as a weighing scale and a pedometer (#11), a health booklet (#19) or a sheet with the risk assessment results (#4 and 7). Two of the studies underline that the nurses aimed to involve the patients' partner or family in the education provided (#24 and 26).
One of the major roles for the nurses is referring people with increased risk, due to one or several risk factors, to other available health care resources (Table 1) .
Education of nurses who perform risk assessment and risk management
In some of the included studies the nurses, who were undertaking CVR assessment and or management, had received short training in advance. The training included Motivational Interviewing, shared decisionmaking, risk assessment, risk communication, and the distribution of decision aids (#4, 5, 15, 17 and 20) .
Video recordings of the nurses' consultations are used in one study in order to provide feedback by medical psychologists (#5). 
Examples of CV risk assessment and management in patients with IA
The following section provides case studies from five European countries (England, The Netherlands, Denmark, Spain and Portugal), the national guidelines for CVR assessment and management in patients with IA and the nurses' involvement in this task. The examples are based on individual rheumatology centres and are therefore not representative for the respective countries.
The UK
In the UK, CVR monitoring has been guided by three guidelines ( implemented annual reviews within nurse-led clinics, but the evidence of the implementation is only starting to emerge especially in nurse-led rheumatology centres (Cornell et al. 2014 , Tugnet et al. 2013 , Gordon et al. 2015 and in primary care (Monk et al. 2013 , Forgie et al. 2015 , Hider et al. 2015 .
One example of such services is the setup of a nurse-led annual review clinic in Darent Valley Hospital.
During the clinic appointment (which lasts for 30 minutes) several assessments are carried out including disease activity, comorbidities including CVR (using QRISK) as well as falls and fracture risks using Furthermore, the centre has setup an interactive patient education service ("Managing my heart and arthritis") for patients with IA and CVR which is run by the rheumatology nurse in cooperation with the cardiology nurse specialist.
The Netherlands
In the Netherlands, CVR assessment and management by nurses take place mainly in primary care settings, where practice nurses work closely with GPs, communicating results and supporting them in CVR management. This intervention is guided by The Dutch Standard for General Practitioners A position paper regarding CVR management published by The Dutch Society for Rheumatology (Nurmohamed et al. 2007) states that in patients with RA, CVR (e.g. blood pressure, cholesterol levels)
should be assessed and registered and appropriate follow up should take place.
At present, CVR assessment and management are not carried out systematically in people with IA. If the patient's CVR is assessed by rheumatology nurses, it is usually only in people with RA and the SCORE tool is used for risk assessment. Patients with an increased CVR are referred to their GP for treatment and follow up.
In Maastricht University Medical Centre, Maastricht, the Netherlands, systematic CVR assessment in patients with gout by rheumatologists and nurses has been initiated. In case of an increased Framingham score (>10%), the patients are referred to their GP for follow-up. The program is planned to embrace patients with RA and Spondyloarthritis (SpA) in the future.
Denmark
The Danish Rheumatologists society incorporated CVR assessment and management in their most recent guideline (Asmussen 2012 ) based on the EULAR recommendations (Peters et al. 2010) , recent guidelines from the Danish Cardiology Association (Hildebrandt et al. 2010 ) and the Danish Association for General
Practice (Christensen et al. 2007) . Yearly screening for patients with RA is recommended, but there may be longer intervals depending on the patient's risk. The European SCORE model is recommended for risk assessment using Total/ HDL-cholesterol ratio (Conroy et al. 2003 , Asmussen 2012 .
At King Christian X's Hospital for Rheumatic Diseases in Graasten, Denmark, nurse-led CVR assessment and management for patients with RA was initiated in September 2011 (Primdahl et al. 2013) which is used in the clinic by the majority of rheumatologists, includes all the risk factors needed for calculating the SCORE or mSCORE. However in the registry, these factors are not aggregated together to ease the calculation of any risk score. In the registry, the only aggregated value that generates a 'red flag'
is an abnormal BMI.
When rheumatologists identify a recurrent elevated risk factor at the rheumatology department at Centro Hospitalar e Universitário de Coimbra, (e.g. hypertension) they may initiate medication, provide brief lifestyle advice or refer the patient for follow-up by a cardiologist or GPs. To the best of our knowledge, nurses are not yet involved in CVR assessment or management in people with IA in Portugal.
DISCUSSION
Our review shows that European nurses undertake CVR assessment and management in many different types of patients and in both hospitals and primary health care settings. Overall the CVR assessments include history taking (family history, smoking, alcohol, diet and physical activity) and measurements (BMI, waist circumference, BP, blood lipids and glucose level). The evidence regarding the use of waist circumference or waist-hip ratio to predict CVR instead of BMI is not clear, but all three measures are highly associated to CV disease (Perk et al. 2013 ) and waist circumference may be useful to illustrate an abdominal weight problem to the patient. The WHO thresholds for waist circumference in European populations are based on Caucasians and are widely used (Perk et al. 2013 ), but they should be adjusted according to ethnic group (Hill 2007 , Tillin et al. 2014 . SCORE and Framingham were the most used tools to calculate the patients' CVR, but other tools were also used.
Despite the fact that patients with RA have an increased risk similar to that in diabetes ), both our review, the country-specific descriptions and other studies indicate that the implementation of CVR assessment and management in patients with IA is still scarce irrespective of whether this role is undertaken by rheumatologists, GPs or nurses (Peters and Nurmohamed 2013 , Monk et al. 2013 , Garcia-Diaz and Corominas 2013 . Only two of the included studies described nurse-led CVR assessment and management in rheumatology (Primdahl et al. 2013 , Dougados et al. 2014 .
As indicated by the country specific descriptions there are unsolved decisions regarding who should perform CVR assessment and management and how this should be organized and this is supported in the literature (Dessein and Semb 2013, van den Oever et al. 2013) . Furthermore the rheumatologists may find it difficult to allocate time for CVR assessment and they may not feel that CVR management is part of their core tasks. These issues may explain part of the inertia to implement systematic screening in patients with IA. A French multicentre RCT reported the first results from comprehensive nurse-led screening of comorbidities including CV disease in patients with RA with a positive impact on several CVR outcomes (Dougados et al. 2014) , but more evidence is needed regarding the effectiveness of CVR screening and management.
It is important to acknowledge that pharmacological treatment to control the inflammation is a very important part of the efforts needed to achieve a reduced CVR (van den Oever et al. 2013 , Choy et al. 2014 ). This is an important task for the rheumatologist or nurses where they undertake extended roles.
The initiation and titration of antihypertensive and lipid lowering therapy in patients with increased CVR can be managed in cooperation between the rheumatology nurse and the rheumatologist or by referral to the patient's GP. Also, nurses are described to have an important role in discussing current medication and adherence issues with the patient.
An unsupportive social environment can have a strong negative influence on the individual's health related behaviour and socially deprived persons may be less capable of becoming actively engaged in their own health (Andric and Vuletic 2012) . The nurse should avoid focusing only on the individual choice and responsibility as CVR depends on socio-economic status as well, in terms of educational level and income, job and living conditions in a broader sense (Perk et al. 2013 , Vallgarda 2011 .
In order to avoid a 'tick the box' culture or becoming just 'risk police' (Boase et al. 2012) , nurses need to engage with the individual patient and help support the patient's risk perception and make CVR meaningful to patients. This requires that nurses explore the patient's social context, emotions, preferences and motivation, regarding life-style modifications and the barriers and possibilities for changes. Furthermore the nurse should try to empower the patient, individualise the education and respect the patient's own choices as described in some of the included studies (Boase et al. 2012 , Andric and Vuletic 2012 , Pavic et al. 2009 , Chamney et al. 2009 , Sol et al. 2008 ).
Appropriate training has been shown to affect the counselling to become patient-centred and focused (Drevenhorn et al. 2009 ). Training of the nurses who perform CVR assessment and management should include how to assess the different risk factors in order to achieve reliable measures, how to calculate a risk score, risk management including a patient centred approach and theoretical health pedagogy for risk communication and how to motivate and support the patient to achieve the goals they would like to pursue. While initial training is important, other measures (such as further training) should be put in place in order to prevent errors. A Dutch study reported that despite 75 minutes training, nurses made small but important errors in risk calculation of high risk patients; errors that could lead to missed opportunities for risk-reducing interventions (Koelewijn-van Loon et al. 2011 ). In the Danish study, the risk calculation (SCORE) was performed electronically (Primdahl et al. 2013 ) and thus manual mistakes could be prevented although emphasis would then need to be put on preventing entry errors.
Strengths and limitations of the study
This was a limited systematic literature review; therefore there will probably be relevant studies that have not been included. Also there may be additional content of the nurses risk assessment and management which was not described in the included studies. The aim of our literature search was to explore nurses' role in assessing and managing CVR in Europe, in order to suggest topics for practice development and research in this area regarding persons with IA. We excluded non-European articles, which could be seen as another limitation, but knowing that the nurses' education, skills and how health care is organized across Europe varies, we did not want to add further differences. Since we were interested in the descriptions of risk assessment and management, rather than effectiveness of interventions, we did not perform a formal assessment of the quality or risk of bias of the included studies. Lastly, the examples given in our country case studies may not be generalizable since clinical practice varies from centre to centre within each country. The main strength of this study is having an international collaboration with different perspectives and real examples of nurses' role in CVR assessment and management. The results of this study could form a strong basis for future research.
Implications for future research
Further research is needed to investigate the clinical effectiveness and cost-effectiveness of nurse-led risk assessment and management in reducing patients' risk for development of diabetes and CV disease.
Secondly, further research is required to assess how risk can be communicated in a meaningful way to the patient and how often (Waldron et al. 2011) . Future research in this area needs to provide accurate descriptions of (i) how the nurses are trained in undertaking CVR assessment and management, (ii) which risk factors are assessed by the nurses, (iii) how nurses assess the CV risk factors and (iv), how the nurses communicate risk, (v) how nurses manage CV risk and (vi) how nurses and the rheumatologists collaborate with the GPs, practice nurses and other health professionals to optimise CVR assessment and management. Screening for risk of a disease is likely to lead to both positive and negative reactions in the patients. So far only one recent study has explored RA patients' experiences from participation in nurseled CVR (Frølund and Primdahl 2015) . Therefore more qualitative studies of the patients' experiences from participation in different versions of CVR assessment and management and their risk perception in IA are needed. Lastly, the effectiveness of telemedicine and ubiquitous computing (such as smartphone apps) in risk assessment and management for people with IA needs to be explored.
CONCLUSION
European nurses perform assessment of known CVR factors (BP, BMI, waist circumference, glucose and lipid-profile, adherence to medication, unhealthy diet, physical inactivity, excess alcohol use and smoking) and calculate the patient's risk score in different groups of patients.
Risk management differ from brief advice to long-term follow-up. The nurses focus on patient involvement, adherence to medications, preferences, barriers, motivation and resources for life-style modifications. The nurses refer the patients for further follow up by their rheumatologist, GP or resources in primary care. Antihypertensive, lipid lowering and diabetes medications can be initiated and titrated by the rheumatologist, the GP or nurses with extended roles depending on the national context.
With appropriate training it is considered to be a highly relevant task for rheumatology nursing to perform CVR assessment, to communicate and manage CVR and provide relevant patient education, especially in patients with IA. Further studies are needed to assess the patients' perspective, effectiveness and costeffectiveness of nurse-led CVR assessment and management in reducing patients' risk for development of diabetes and CV disease.
